Skip to content
OpenCapital
Get started

Bausch Health Companies BHC Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

Henry Schein logo
Henry ScheinHSIC
$120M+34.8%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.86B-15.9%

Profitability

See full
Gross margin71.4%—
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%—
Debt / equity45.2×—
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's cash provided by (used in) financing activity, including discontinued operation?
Bausch Health Companies (BHC) reported cash provided by (used in) financing activity, including discontinued operation of -$100M in Q1 2026.
How has Bausch Health Companies's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
Bausch Health Companies's cash provided by (used in) financing activity, including discontinued operation increased by 31.5% year-over-year, from -$146M to -$100M.
What is the long-term trend for Bausch Health Companies's cash provided by (used in) financing activity, including discontinued operation?
Over 3 years (2022 to 2025), Bausch Health Companies's cash provided by (used in) financing activity, including discontinued operation has grown at a 16.1% compound annual growth rate (CAGR), from -$474M to -$742M.
What does cash provided by (used in) financing activity, including discontinued operation mean?
This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.